Latest News

Unleashad

European_Commission.svg

TILT won a grant for a 2.5 M€ (~$ 2.9M) project, entitled UNLEASHAD, from the European Commission EIC SME Instrument. The grant will be used to perform a Phase 1 clinical trial with the company’s lead drug, TILT-123. Read the press release here.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

31st May - 4th June 2024
ASCO Annual Meeting
Chicago (IL), USA
3-6th June 2024
BIO International Convention
San Diego (CA), USA
13-17th September 2024
ESMO Congress 2024
Barcelona, Spain
17-19th September 2024
Nordic Life Science Days (NLSDays)
Malmö, Sweden
27-30th October 2024
16th Annual International Oncolytic Virotherapy Conference
Rotterdam, Netherlands
4-6th November 2024
BIO-Europe
Stockholm, Sweden
20-21st November 2024
SLUSH
Helsinki, Finland
11-13th December 2024
ESMO Immuno-Oncology Congress
Geneva, Switzerland
13-15th January 2025
Biotech Showcase
San Francisco (CA), USA